The contract was based on a recommendation of the TubeClear System by hospital experts in this category who serve on one of Vizient’s member-led councils.

Innovative Technology contracts are reserved for technologies that demonstrate an ability to enhance clinical care or patient safety, and those that improve an organization’s care delivery and business model.

The TubeClear system is an FDA-cleared medical device that uses patented mechanical motion technology to clear occlusions in most enteral access devices (EADs) while the EAD remains in the patient and works at bedside. Clinical research estimates that seven million enteral access devices are placed each year.

With a clogging rate of about 25%, that is 1.7 million patients experiencing interruptions to their nutrition and medication due to clogged feeding tubes every year. Replacement risks include misplacement into the lungs, which can lead to pneumothorax and even death.

Keeping these EADs clear prevents interruptions to feeding and medication delivery, allowing clinicians to maintain their focus on improving patient care and reducing healthcare costs associated with tube replacement. The TubeClear system is the only powered mechanical system for clearing EADs on the market.

Bench top analysis confirms that it is faster and more effective than current solutions such as flushing with water or using enzyme-based treatments. The system, which is comprised of reusable control boxes and single-use clearing stems, is designed, developed, and manufactured by Actuated Medical in Bellefonte, PA.

Actuated Medical president and CEO Maureen Mulvihill said: “We’re excited to be recognized as an innovative technology provider that is improving patient outcomes.

“Having a Vizient awarded contract, the TubeClear System allows members to have access to increased savings.”

The new multi-year contract for the TubeClear System began on 1 November this year.

Vizient’s Innovative Technology program for suppliers leader and procurement director Debbie Archer said: “After a full review of the TubeClear System, Vizient’s member council agreed this solution offers unique and incremental benefit over other products available on the market today, and recommended it for an innovative technology contract. We are pleased to award this new contract to Actuated Medical.”

Vizient represents a diverse membership base that includes academic medical centers, pediatric facilities, community hospitals, integrated health delivery networks and non-acute health care providers and represents approximately $100bn in annual purchasing volume.

Through its Innovative Technology Program, Vizient works with member-led councils and task forces to review potentially innovative products. If it is determined that a product is innovative, Vizient may award a contract outside of the competitive bid cycle.

Source: Company Press Release